Getting better value from the NHS drug budget

BMJ. 2010 Dec 17:341:c6449. doi: 10.1136/bmj.c6449.
No abstract available

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / economics*
  • Budgets
  • Drugs, Generic / economics*
  • Health Care Reform
  • Heart Failure / drug therapy
  • Heart Failure / economics
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hypertension / drug therapy
  • Hypertension / economics
  • Losartan / economics*
  • Patents as Topic
  • Practice Patterns, Physicians'
  • Prescription Drugs / economics
  • Simvastatin / economics*
  • State Medicine / economics*
  • United Kingdom

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Drugs, Generic
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Prescription Drugs
  • Simvastatin
  • Losartan